Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined...
Patent
1997-01-02
1999-02-02
Naff, David M.
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
424572, 435325, 435366, 435378, 435379, 435380, 435395, 435404, 435405, A61K 3512, C12N 500, C12N 508
Patent
active
058661670
ABSTRACT:
Cultures of keratinocyte cells are provided which are free from nonautologous fibroblasts and organ extracts, and which have a high speed of cell amplification for a minimum seeding density. Preferably, a culture contains no more than about 10% autologous non-keratinocyte cells such as star-shaped, non-keratinocyte cells and no more than about 1% autologous fibroblasts. The cultures can be cryopreserved in a buffered isotonic medium containing serum and a cryoprotectant. The cultures are produced by a process that does not involve the use of a feeder layer and organ extracts. A culture medium used contains Medium 199, serum, epidermal growth factor, cholera toxin and/or hydrocortisone, and optionally insulin. A substance for wound healing and for cosmetic applications is derived from cultured human keratinocytes. Lyophilized keratinocyte cell cultures or an extract therefrom is used to provide a pharmaceutical composition. Confluent and cohesive keratinocyte sheets are prepared for use in wound healing. A non-viable total keratinocyte lysate for use in promoting wound healing is produced by growing keratinocyte cells on a support, detaching the cells from the support, and lysing the detached cells to obtain the lysate. The lysate may be frozen and lyophilized. The detached cells may be frozen to produce the lysate without lysis before freezing.
REFERENCES:
patent: 4016036 (1977-04-01), Green et al.
patent: 4254226 (1981-03-01), Eisinger et al.
patent: 4299819 (1981-11-01), Eisinger
patent: 4304866 (1981-12-01), Green et al.
patent: 4443546 (1984-04-01), Stemerman et al.
patent: 4673649 (1987-06-01), Boyce et al.
patent: 4888291 (1989-12-01), Barrandon et al.
patent: 4940666 (1990-07-01), Boyce et al.
patent: 4996154 (1991-02-01), Gabriels, Jr.
patent: 5000963 (1991-03-01), Hefton
patent: 5130142 (1992-07-01), Wong et al.
patent: 5262298 (1993-11-01), Shipley et al.
patent: 5273877 (1993-12-01), Fey et al.
patent: 5273900 (1993-12-01), Boyce
patent: 5460939 (1995-10-01), Hansbrough et al.
Ausubel et al., F.M., Short Protocols in Molecular Biology, 2nd ed. 1992, pp. 4-11-4-12.
Eisinger et al., M., Growth regulation of skin cells by epidermal cell-derived factors: Implications for wound healing, vol. 85, pp. 1937-1941, Mar. 1988, Proc. Natl. Acad. Sci., USA.
Kalish, R.S., The Journal of Immunology, Jan. 1989, vol. 142(1), pp. 74-80.
Maleiczyk et al, Int. J. Cancer, Feb. 1989, vol. 43(2), pp. 209-214.
Marcelo et al. Stratification, Specialization, and Proliferation . . . , Journal of Cell Biology, vol. 79, No. 2, Nov. 1978, pp. 356-370.
Peehl et al., D.M., Growth and Differentiation of Human Keratinocytes . . . , In Vitro, vol. 16, No. 6, Jun. 1980, pp. 516-525.
Peehl et al.,Clonal Growth of Human Keratinocytes . . . , Embase, Excerpta Medica, Amsterdam, NL. Abstract No. 81021358.
Pittelkow et al., New Techniques for the In Vitro..., Mayo Clinic Proceedings, vol. 61, No. 10, Oct. 1986, Database WPIL, Week 8947, Derwent Publications Ltd., London, BG.
Schmidt et al., R., The Journal of Investigative Dermatology, Jul. 1985, vol. 85(1), pp. 50-53.
Zyskind et al., W., Recombinant DNA Laboratories Manual, 1989, pp. 12-17.
N.V Innogentics S.A.
Naff David M.
LandOfFree
Non-viable total keratinocyte lysate for promoting wound healing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-viable total keratinocyte lysate for promoting wound healing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-viable total keratinocyte lysate for promoting wound healing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1114839